FIELD: medicine, pulmonology.
SUBSTANCE: along with analyzing pulmonary symptoms and functions, one should additionally evaluate procoagulant activity of plasmatic blood phospholipid membranes by the value of kaolin terms for clotting. At its value being 108.5±2.9 sec it is easy to state upon light intermittent bronchial asthma (BA), at 99.4±1.3 sec - on light persisting BA, at 116.5±3.1 sec - on average BA, at 123.8±4.6 sec - on severe BA. The present innovation is useful in prescribing corresponding curative-rehabilitation procedures.
EFFECT: higher accuracy of diagnostics.
4 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING SEVERITY DEGREE DURING THE PERIOD OF BRONCHIAL ASTHMA EXACERBATION IN CHILDREN | 2002 |
|
RU2239188C2 |
| METHOD OF PREDICTING UNCONTROLLED COURSE OF SEVERE BRONCHIAL ASTHMA | 2011 |
|
RU2470582C1 |
| METHOD OF ASSESSING PRESENCE OF DYSFUNCTION OF SMALL AIRWAYS IN PATIENTS WITH MILD BRONCHIAL ASTHMA | 2022 |
|
RU2806491C1 |
| METHOD OF TREATING BRONCHIAL ASTHMA IN CHILDREN | 2009 |
|
RU2417802C2 |
| METHOD OF CHRONIC OBSTRUCTIVE LUNG DISEASE (BRONCHIAL ASTHMA, CHRONIC OBSTRUCTIVE LUNG DISEASE) MEDICAL TREATMENT | 2006 |
|
RU2326647C2 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR BRONCHIAL ASTHMA | 2012 |
|
RU2497117C2 |
| METHOD OF TREATMENT OF CHILDREN'S BRONCHIAL ASTHMA | 1996 |
|
RU2128526C1 |
| METHOD FOR ASSESSING THE DEGREE OF RISK OF MAJOR RESPIRATORY DYSFUNCTION DEVELOPMENT IN PATIENTS WITH EARLY STAGES OF BRONCHIAL ASTHMA | 2020 |
|
RU2741858C1 |
| METHOD FOR ASSESSING AND PREDICTING THE RISK OF DEVELOPING SMALL AIRWAY DYSFUNCTION IN PATIENTS WITH BRONCHIAL ASTHMA ASSOCIATED WITH OBESITY | 2021 |
|
RU2778070C1 |
| METHOD OF PROGNOSIS OF EFFICIENCY OF BRONCHIAL ASTHMA BASIC THERAPY IN CHILDREN | 2007 |
|
RU2356054C1 |
